Dannell D. Boatman, West Virginia University. For the first time, an mRNA cancer vaccine has succeeded in a late-stage clinical trial, a significant advance that could transform how cancer is treated. On August 19, 2026, Moderna and Merck announced that their personalized vaccine, Intismeran, had achieved success in a late-stage clinical trial.
The post Cancer vaccines could transform treatment and prevention, but misinformation threatens their …